JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M611048200 on December 22, 2006

J. Biol. Chem., Vol. 282, Issue 8, 5195-5200, February 23, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow An addition or correction has been published
Right arrow All Versions of this Article:
282/8/5195    most recent
M611048200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cuellar, K.
Right arrow Articles by Hinsdale, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cuellar, K.
Right arrow Articles by Hinsdale, M. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Biosynthesis of Chondroitin and Heparan Sulfate in Chinese Hamster Ovary Cells Depends on Xylosyltransferase II*Formula

Karen Cuellar1, Hoa Chuong, Sherry M. Hubbell, and Myron E. Hinsdale2

From the Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation and Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104

Xylosyltransferase (XylT) catalyzes the initial enzymatic reaction in the glycosaminoglycan assembly pathway for proteoglycan biosynthesis. Its activity is thought to be rate-limiting. Two xylosyltransferases have been found using genomic analyses, and one of these, XylT1, has been shown to have xylosyltransferase activity. On the other hand, the less studied XylT2 in recombinant form lacks xylosyltransferase activity and has no known function. Wild-type Chinese hamster ovary cells express abundant Xylt2 mRNA levels and lack detectable Xylt1 mRNA levels. Analysis of a previously described Chinese hamster ovary cell xylosyltransferase mutant (psgA-745) shows that it harbors an Xylt2 nonsense mutation and fails to assemble glycosaminoglycans onto recombinant biglycan. Transfection of this cell line with a murine Xylt2 minigene results in the production of recombinant chondroitin sulfate-modified biglycan core protein and restoration of fibroblast growth factor binding to cell surface-associated heparan sulfate. Expression analyses on 10 different human transformed cell lines detect exclusive XYLT2 expression in two and co-expression of XYLT1 and XYLT2 in the others but at disparate ratios where XYLT2 expression is greater than XYLT1 in most cell lines. These results indicate that XylT2 has a significant role in proteoglycan biosynthesis and that cell type may control which family member is utilized.


Received for publication, October 16, 2006 , and in revised form, December 18, 2006.

* This work was supported by American Heart Association Grant 0265270Z and National Institutes of Health Grant P20 RR018758. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains a supplemental figure and a supplemental table.

1 Present address: Integrative Biology Graduate Program, University of Texas Southwestern Medical Center at Dallas, 6001 Forest Park Rd., Dallas, TX 75390.

2 To whom correspondence should be addressed: Cardiovascular Biology Research Program, 825 NE 13th St. MS#45, Oklahoma City, OK 73104. Tel.: 405-271-7073; Fax: 405-271-7417; E-mail: Myron-Hinsdale{at}omrf.ouhsc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Prante, H. Milting, A. Kassner, M. Farr, M. Ambrosius, S. Schon, D. G. Seidler, A. E. Banayosy, R. Korfer, J. Kuhn, et al.
Transforming Growth Factor beta1-regulated Xylosyltransferase I Activity in Human Cardiac Fibroblasts and Its Impact for Myocardial Remodeling
J. Biol. Chem., September 7, 2007; 282(36): 26441 - 26449.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Condac, R. Silasi-Mansat, S. Kosanke, T. Schoeb, R. Towner, F. Lupu, R. D. Cummings, and M. E. Hinsdale
Polycystic disease caused by deficiency in xylosyltransferase 2, an initiating enzyme of glycosaminoglycan biosynthesis
PNAS, May 29, 2007; 104(22): 9416 - 9421.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Voglmeir, R. Voglauer, and I. B. H. Wilson
XT-II, the Second Isoform of Human Peptide-O-xylosyltransferase, Displays Enzymatic Activity
J. Biol. Chem., March 2, 2007; 282(9): 5984 - 5990.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.